Genomics Market by Product and Services (Instruments/Systems, Consumables, Services), Technology (Sequencing, Microarray, PCR), Process (Library Preparation, Sequencing, Data Analysis), Application (Diagnostics) - Forecast to 2022

The global Genomics market has been valued at USD 13.45 Billion in 2016 and is expected to grow at a CAGR of 10.2% to reach to USD 23.88 Billion by 2022. The growth of the overall market for genomics can be attributed to the growing demand for personalized medicine, growing investments, grants, and funds by the government; rise in research activities in the field of genomics; increasing number of start-up companies; and increasing application of genomic sequencing in the diagnostics. In the coming years, North America is expected to account for the largest share of the global Genomics market. Base year considered for the report is 2016 and the forecast period includes 2017–2022.

Objectives of the Study:

• To define, describe, and measure the global genomics Genomics market by products and services, technology, process, application, end user, and region
• To provide detailed information regarding the major factors, such as drivers, restraints, growth opportunities, and challenges influencing the growth of the Genomics market
• To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the global Genomics market for genomics
• To analyze the opportunities in the global market for key stakeholders and provide details of the competitive landscape for major market leaders
• To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World
• To strategically analyze the Genomics market structure and profile the key players of the global market for genomics and comprehensively analyze their core competencies
• To benchmark players within the market using proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy
• To track and analyze competitive developments such as partnerships, agreements, alliances, joint ventures, collaborations, product launches, expansions, acquisitions, grants/funds, and licensing agreements, among others in the Genomics market.

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global Genomics market and estimate the size of other dependent submarkets. Various secondary sources such as associations like the International Chromosome and Genome Society (ICGS), International Mammalian Genome Society, Center for Genomics and Society, Association of Environmental Mutagenesis and Genomics Societies (IAEMGS), National Human Genome Research Institute (NHGRI), the American Society of Human Genetics, Genetics Society of America (GSA), Genome Canada, European Society of Human Genetics (ESHG), British Society for Human Genetics, Genetic Society of China (GSC), the Genetic Society of Japan, Indian Society of Genetics, Biotechnology Research & Development, the Indian Society of Genetics and Plant Breeding (ISGPB), Human Genetics Society of Australasia, Brazilian Association of Mutagenesis and Environmental Genomics, and Brazilian Society of Genetics, directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of the Genomics market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of Genomics market. The breakdown of profiles of primaries is shown in the figure below:

To know about the assumptions considered for the study, download the pdf brochure

The various players in the Genomics market include Thermo Fisher Scientific (US), Agilent Technologies, (US), Illumina (US), Eurofins Scientific (Germany), QIAGEN (Netherlands), BGI (China), GE Healthcare (UK), Bio-Rad Laboratories (US), F. Hoffmann-La Roche (Switzerland), Oxford Nanopore Technologies (UK), Pacific Biosciences of California (US), and Eppendorf (Germany) among others.

Target Audience:

• Genomics products and services companies and distributors
• Genomics instrument and consumables manufacturers and suppliers
• Out–licensing life sciences companies (pharmaceutical/biopharmaceutical/biotechnology)
• In–licensing life sciences companies (pharmaceutical/biopharmaceutical/biotechnology)
• Genomics research organizations
• Academic institutes
• Government and private research institutes
• Medical research centers
• Public and private health agencies
• Genomics and biotechnology associations
• Business consultancies
• Venture capitalists

Scope of the Report:

The research report categorizes the global market for genomics into the following segments and sub-segments:

Genomics Market, by Product and Services 

• Instruments/Systems
• Consumables
• Services

Genomics Market, by Technology

• Sequencing
• Microarray
• PCR (Polymerase Chain Reaction)
• Nucleic Acid Extraction and Purification
• Other Technologies (Genotyping, Gene Expression and Gene editing among others)

Genomics Market, by Technology

• Library Preparation
• Sequencing
• Dsata Analysis

Genomics Market, by Application

• Diagnostics
• Drug Discovery and Development
• Precision Medicine
• Agriculture and Animal Research
• Other applications (Marine Research, biofuels, and coal mines among others)

Genomics Market, by End User

• Research Centers, Academic and Government Institutes
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Other End Users (NGOs, and agri-genomics organizations among others)

Genomics Market, by Region

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • ROE
• Asia Pacific
  • China
  • India
  • Japan
  • ROAPAC
• Rest of the World (RoW)
  • Latin America
  • Middle East and Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Portfolio Analysis

• Product Matrix, which gives a detailed comparison of the product portfolio of each company

Company Information

• Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Genomics Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Methodology Steps
    2.2 Secondary Research
           2.2.1 Key Data From Secondary Sources
    2.3 Primary Research
           2.3.1 Key Industry Insights
           2.3.2 Key Data From Primary Sources
           2.3.3 Key Insights From Primary Sources
    2.4 Genomics Market Size Estimation Methodology
    2.5 Market Forecast Methodology
    2.6 Genomics Market Data Validation and Triangulation
    2.7 Assumptions for the Study

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 37)
    4.1 Genomics: Market Overview
    4.2 Genomics Market, By Product and Service, 2017 vs 2022, (USD Billion)
    4.3 Market, By Technology, 2017 vs 2022
    4.4 Genomics Market, By Process, 2017 vs 2022, (USD Billion)
    4.5 Market, By Application, 2017 vs 2022 (USD Billion)
    4.6 Geographic Analysis of the Genomics Market, By End User, 2017 vs 2022
    4.7 Geographic Snapshot of the Genomics Market

5 Market Overview (Page No. - 43)
    5.1 Introduction
    5.2 Genomics Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Government Funding and Growth in the Number of Genomics Projects
                    5.2.1.2 Decreasing Sequencing Costs
                    5.2.1.3 Growing Application Areas of Genomics
                    5.2.1.4 Entry of New Players and Start-Ups in the Genomics Market
           5.2.2 Restraints
                    5.2.2.1 High Cost of Equipment Used in Genomics
           5.2.3 Opportunities
                    5.2.3.1 Use of Genomics in Specialized/Personalized Medicine
           5.2.4 Challenges
                    5.2.4.1 Dearth of Trained Professionals
                    5.2.4.2 Secure Storage of Large Volumes of Sequenced Data

6 Global Genomics Market, By Product and Service (Page No. - 49)
    6.1 Introduction
    6.2 Instruments/Systems
    6.3 Consumables
    6.4 Services

7 Global Genomics Market, By Technology (Page No. - 57)
    7.1 Introduction
    7.2 Sequencing
    7.3 Microarray
    7.4 PCR
    7.5 Nucleic Acid Extraction and Purification
    7.6 Other Technologies

8 Global Genomics Market, By Process (Page No. - 67)
    8.1 Introduction
    8.2 Sequencing
    8.3 Library Preparation
    8.4 Data Analysis

9 Global Genomics Market, By Application (Page No. - 72)
    9.1 Introduction
    9.2 Diagnostics
           9.2.1 Cancer Diagnostics
           9.2.2 Monogenic (Mendelian) Disorders
           9.2.3 Other Diagnostic Applications
                    9.2.3.1 Common Diseases and Complex Disorders
                    9.2.3.2 Movement Disorders
                    9.2.3.3 HIV
    9.3 Drug Discovery and Development
    9.4 Precision Medicine
    9.5 Agriculture & Animal Research
    9.6 Other Applications

10 Global Genomics Market, By End User (Page No. - 82)
     10.1 Introduction
     10.2 Research Centers and Academic & Government Institutes
     10.3 Hospitals and Clinics
     10.4 Pharmaceutical & Biotechnology Companies
     10.5 Other End Users

11 Global Genomics Market, By Region (Page No. - 91)
     11.1 Introduction
     11.2 North America
             11.2.1 US
                        11.2.1.1 Research Grants and Funding By Government Institutes
                        11.2.1.2 Precision Medicine Initiative
                        11.2.1.3 Growing Focus of Industry Players in the US Market
                        11.2.1.4 Increasing Use of GM Crops
             11.2.2 Canada
                        11.2.2.1 Availability of Research Funding in Canada
                        11.2.2.2 Gapp to Intensify R&D in Genomics
                        11.2.2.3 Rising Incidence of Cancer in Canada
     11.3 Europe
             11.3.1 UK
                        11.3.1.1 Increased Funds and Grants By Government Bodies
                        11.3.1.2 100,000 Genome Project
             11.3.2 Germany
                        11.3.2.1 Availability of Funding for Life Science Research
                        11.3.2.2 Presence of A Large Number of Academic Institutes
             11.3.3 France
                        11.3.3.1 Increasing Government Investments in Genomics
                        11.3.3.2 Introduction of Non-Invasive Prenatal Testing in France
             11.3.4 RoE
                        11.3.4.1 Growing Research Investments in Sweden & Denmark
     11.4 Asia Pacific
             11.4.1 China
                        11.4.1.1 Government Initiatives to Improve Healthcare Sector in China
                        11.4.1.2 Efforts of BGI to Boost the Chinese Genomics Market
             11.4.2 India
                        11.4.2.1 Emergence of Local Players in India Backed By Government Funding
                        11.4.2.2 Increasing Support for Biotech Start-Ups
             11.4.3 Japan
                        11.4.3.1 Increasing Government Focus on Cancer Research
             11.4.4 Rest of Asia Pacific
                        11.4.4.1 Strategic Alliances and Partnerships in the Australian Genomics Market
     11.5 Rest of the World (RoW)
             11.5.1 Middle East and Africa
                        11.5.1.1 Genetic Testing and Genomic Analysis in the Middle East
                        11.5.1.2 Rising Prevalence of HIV and Cancer in Africa
             11.5.2 Latin America
                        11.5.2.1 Increasing Government Funding in Brazil
                        11.5.2.2 Conferences & Workshops in Brazil

12 Competitive Landscape (Page No. - 154)
     12.1 Genomics Market Share Analysis

13 Company Profiles (Page No. - 157)
(Overview, Products and Services, Financials, Strategy & Development)*
     13.1 Illumina
     13.2 Agilent Technologies
     13.3 Thermo Fisher Scientific
     13.4 Eurofins Scientific
     13.5 Qiagen
     13.6 GE Healthcare
     13.7 F. Hoffmann-La Roche
     13.8 Oxford Nanopore Technologies
     13.9 Bio-Rad Laboratories
     13.10 BGI
     13.11 Eppendorf
     13.12 Pacific Biosciences of California
     13.13 Danaher

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 209)
     14.1 Discussion Guide
     14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.3 Introducing RT: Real-Time Market Intelligence
     14.4 Available Customizations
     14.5 Related Reports
     14.6 Author Details

List of Tables (112 Tables)

Table 1 Genomics Market, By Product and Service, 2015–2022 (USD Million)
Table 2 Genomics Instruments/Systems Market, By Country, 2015–2022 (USD Million)
Table 3 Genomics Consumables Market, By Country, 2015–2022 (USD Million)
Table 4 Genomics Services Market, By Country, 2015–2022 (USD Million)
Table 5 Market, By Technology, 2015–2022 (USD Million)
Table 6 Market for Sequencing, By Country, 2015–2022 (USD Million)
Table 7 Genomics Market for Microarrays, By Country, 2015–2022 (USD Million)
Table 8 Market for PCR, By Country, 2015–2022 (USD Million)
Table 9 Market for Nucleic Acid Extraction and Purification, By Country, 2015–2022 (USD Million)
Table 10 Genomics Market for Other Technologies, By Country, 2015–2022 (USD Million)
Table 11 Market, By Process, 2015–2022 (USD Million)
Table 12 Market for Sequencing, By Country, 2015–2022 (USD Million)
Table 13 Market for Library Preparation, By Country, 2015–2022 (USD Million)
Table 14 Genomics Market for Data Analysis, By Country, 2015–2022 (USD Million)
Table 15 Market, By Application, 2015–2022 (USD Million)
Table 16 Genomics Market for Diagnostics, By Country, 2015–2022 (USD Million)
Table 17 Market for Drug Discovery and Development, By Country, 2015–2022 (USD Million)
Table 18 Market for Personalized Medicine, By Country, 2015–2022 (USD Million)
Table 19 Genomics Market for Agriculture and Animal Research, By Country, 2015–2022 (USD Million)
Table 20 Market for Other Applications, By Country, 2015–2022 (USD Million)
Table 21 Market, By End User, 2015–2022 (USD Million)
Table 22 Genomics Market for Research Centers and Academic & Government Institutes, By Country, 2015–2022 (USD Million)
Table 23 Market for Hospitals and Clinics, By Country, 2015–2022 (USD Million)
Table 24 Genomics Market for Pharmaceutical and Biotechnology Companies, By Country, 2015–2022 (USD Million)
Table 25 Genomics Market for Other End Users, By Country, 2015–2022 (USD Million)
Table 26 Market, By Region, 2015–2022 (USD Million)
Table 27 North America: Genomics Market, By Country, 2015–2022 (USD Million)
Table 28 North America: Market, By Product & Service, 2015–2022 (USD Million)
Table 29 North America: Market, By Technology, 2015–2022 (USD Million)
Table 30 North America: Genomics Market, By Process, 2015–2022 (USD Million)
Table 31 North America: Market, By Application, 2015–2022 (USD Million)
Table 32 North America: Genomics Market, By End User, 2015–2022 (USD Million)
Table 33 US: Genomics Market, By Product & Service, 2015–2022 (USD Million)
Table 34 US: Genomics Market, By Technology, 2015–2022 (USD Million)
Table 35 US: Market, By Process, 2015–2022 (USD Million)
Table 36 US: Market, By Application, 2015–2022 (USD Million)
Table 37 US: Genomics Market, By End User, 2015–2022 (USD Million)
Table 38 Indicative List of Projects Funded By Gapp in 2014
Table 39 Canada: Genomics Market, By Product & Service, 2015–2022 (USD Million)
Table 40 Canada: Market, By Technology, 2015–2022 (USD Million)
Table 41 Canada: Market, By Process, 2015–2022 (USD Million)
Table 42 Canada: Genomics Market, By Application, 2015–2022 (USD Million)
Table 43 Canada: Market, By End User, 2015–2022 (USD Million)
Table 44 Conferences/Meetings/Courses/Workshops Held in Europe
Table 45 Europe: Genomics Market, By Country, 2015–2022 (USD Million)
Table 46 Europe: Market, By Product & Service, 2015–2022 (USD Million)
Table 47 Europe: Market, By Technology, 2015–2022 (USD Million)
Table 48 Europe: Market, By Process, 2015–2022 (USD Million)
Table 49 Europe: Market, By Application, 2015–2022 (USD Million)
Table 50 Europe: Genomics Market, By End User, 2015–2022 (USD Million)
Table 51 UK: Market, By Product & Service, 2015–2022 (USD Million)
Table 52 UK: Market, By Technology, 2015–2022 (USD Million)
Table 53 UK: Genomics Market, By Process, 2015–2022 (USD Million)
Table 54 UK: Market, By Application, 2015–2022 (USD Million)
Table 55 UK: Genomics Market, By End User, 2015–2022 (USD Million)
Table 56 Germany: Market, By Product & Service, 2015–2022 (USD Million)
Table 57 Germany: Market, By Technology, 2015–2022 (USD Million)
Table 58 Germany: Genomics Market, By Process, 2015–2022 (USD Million)
Table 59 Germany: Market, By Application, 2015–2022 (USD Million)
Table 60 Germany: Market, By End User, 2015–2022 (USD Million)
Table 61 France: Genomics Market, By Product & Service, 2015–2022 (USD Million)
Table 62 France: Market, By Technology, 2015–2022 (USD Million)
Table 63 France: Market, By Process, 2015–2022 (USD Million)
Table 64 France: Market, By Application, 2015–2022 (USD Million)
Table 65 France: Genomics Market, By End User, 2015–2022 (USD Million)
Table 66 RoE: Genomics Market, By Product & Service, 2015–2022 (USD Million)
Table 67 RoE: Market, By Technology, 2015–2022 (USD Million)
Table 68 RoE: Market, By Process, 2015–2022 (USD Million)
Table 69 RoE: Market, By Application, 2015–2022 (USD Million)
Table 70 RoE: Genomics Market, By End User, 2015–2022 (USD Million)
Table 71 Asia Pacific: Market, By Country, 2015–2022 (USD Million)
Table 72 Asia Pacific: Genomics Market, By Product & Service, 2015–2022 (USD Million)
Table 73 Asia Pacific: Market, By Technology, 2015–2022 (USD Million)
Table 74 Asia Pacific: Genomics Market, By Process, 2015–2022 (USD Million)
Table 75 Asia Pacific: Market, By Application, 2015–2022 (USD Million)
Table 76 Asia Pacific: Market, By End User, 2015–2022 (USD Million)
Table 77 China: Genomics Market, By Product & Service, 2015–2022 (USD Million)
Table 78 China: Market, By Technology, 2015–2022 (USD Million)
Table 79 China: Market, By Process, 2015–2022 (USD Million)
Table 80 China: Market, By Application, 2015–2022 (USD Million)
Table 81 China: Genomics Market, By End User, 2015–2022 (USD Million)
Table 82 India: Market, By Product and Service, 2015–2022 (USD Million)
Table 83 India: Market, By Technology, 2015–2022 (USD Million)
Table 84 India: Market, By Process, 2015–2022 (USD Million)
Table 85 India: Genomics Market, By Application, 2015–2022 (USD Million)
Table 86 India: Genomics Market, By End User, 2015–2022 (USD Million)
Table 87 Japan: Market, By Product & Service, 2015–2022 (USD Million)
Table 88 Japan: Market, By Technology, 2015–2022 (USD Million)
Table 89 Japan: Market, By Process, 2015–2022 (USD Million)
Table 90 Japan: Genomics Market, By Application, 2015–2022 (USD Million)
Table 91 Japan: Market, By End User, 2015–2022 (USD Million)
Table 92 RoAPAC: Market, By Product & Service, 2015–2022 (USD Million)
Table 93 RoAPAC: Market, By Technology, 2015–2022 (USD Million)
Table 94 RoAPAC: Genomics Market, By Process, 2015–2022 (USD Million)
Table 95 RoAPAC: Market, By Application, 2015–2022 (USD Million)
Table 96 RoAPAC: Market, By End User, 2015–2022 (USD Million)
Table 97 RoW: Market, By Region, 2015–2022 (USD Million)
Table 98 RoW: Genomics Market, By Product & Service, 2015–2022 (USD Million)
Table 99 RoW: Market, By Technology, 2015–2022 (USD Million)
Table 100 RoW: Market, By Process, 2015–2022 (USD Million)
Table 101 RoW: Market, By Application, 2015–2022 (USD Million)
Table 102 RoW: Market, By End User, 2015–2022 (USD Million)
Table 103 Middle East and Africa: Genomics Market, By Product & Service, 2015–2022 (USD Million)
Table 104 Middle East and Africa: Market, By Technology, 2015–2022 (USD Million)
Table 105 Middle East and Africa: Genomics Market, By Process, 2015–2022 (USD Million)
Table 106 Middle East and Africa: Market, By Application, 2015–2022 (USD Million)
Table 107 Middle East and Africa: Market, By End User, 2015–2022 (USD Million)
Table 108 Latin America: Market, By Product & Service, 2015–2022 (USD Million)
Table 109 Latin America: Genomics Market, By Technology, 2015–2022 (USD Million)
Table 110 Latin America: Market, By Process, 2015–2022 (USD Million)
Table 111 Latin America: Genomics Market, By Application, 2015–2022 (USD Million)
Table 112 Latin America: Market, By End User, 2015–2022 (USD Million)

List of Figures (43 Figures)

Figure 1 Global Genomics Market: Research Methodology Steps
Figure 2 Sampling Frame: Primary Research
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Genomics Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Genomics Market Size Estimation Methodology: Top-Down Approach
Figure 6 Research Design
Figure 7 Data Triangulation Methodology
Figure 8 The Services Segment is Expected to Register the Highest CAGR in the Global Genomics Market During the Forecast Period
Figure 9 The Sequencing Segment Expected to Register Highest Growth Rate During the Forecast Period
Figure 10 The Sequencing Segment is Expected to Register the Highest CAGR in the Global Genomics Market During the Forecast Period
Figure 11 The Diagnostics Segment is Expected to Register the Highest CAGR in the Global Genomics Market Between 2017 & 2022
Figure 12 The Research Centers and Academic & Government Institutes Segment Accounted for Largest Share of the Global Genomics Market in 2016
Figure 13 Geographical Snapshot of the Global Genomics Market
Figure 14 Rising Government Funding for Genomics Research is Expected to Drive the Growth of the Genomics Market
Figure 15 Services Segment to Witness Highest Growth Rate During the Forecast Period
Figure 16 PCR (Polymerase Chain Reaction) Technology Segment is Expected to Dominate the market in 2022
Figure 17 The Sequencing Segment to Witness Highest Growth Rate During the Forecast Period
Figure 18 Diagnostics Segment is Expected to Account for the Largest Market Share in 2022
Figure 19 North America to Dominate the Genomics Market
Figure 20 North America to Register the Highest Growth Rate During the Forecast Period
Figure 21 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 22 Market, By Product and Service
Figure 23 Genomics Market, By Technology
Figure 24 Genomics Market, By Process
Figure 25 Diagnostics Segment to Hold Largest Share of the Genomics Market During 2017–2022
Figure 26 Market, By End User
Figure 27 North America to Command the Largest Share of the Global Market in 2017
Figure 28 North America: Market Snapshot
Figure 29 Europe: Market Snapshot
Figure 30 Asia Pacific: Genomics Market Snapshot
Figure 31 RoW: Genomics Market Snapshot
Figure 32 Market Share Analysis, By Key Player, 2016
Figure 33 Illumina: Company Snapshot (2016)
Figure 34 Agilent Technologies: Company Snapshot (2016)
Figure 35 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 36 Eurofins Scientific: Company Snapshot (2016)
Figure 37 Qiagen: Company Snapshot (2016)
Figure 38 General Electric Company: Company Snapshot (2016)
Figure 39 F. Hoffmann-La Roche : Company Snapshot (2016)
Figure 40 Bio-Rad Laboratories: Company Snapshot (2016)
Figure 41 Eppendorf: Company Snapshot (2016)
Figure 42 Pacific Biosciences of California: Company Snapshot (2016)
Figure 43 Danaher : Company Snapshot (2016)

The global Genomics market is expected to reach USD 23.88 Billion by 2022 from USD 14.71 Billion in 2017, at a CAGR of 10.2%. The growth of this market is majorly driven by the rise in research activities in the field of genomics; increasing number of start-up companies; growing focus personalized medicine, growing investments, grants, and funds by the government; and increasing application of genomic sequencing in the diagnostics.

The report analyzes the genomics market by product and services, technology, process, application, end user and region. The products and services of genomics market is segmented into instruments/systems, consumables and services. The consumables segment is estimated to command the largest share of the global market for genomics in 2016. On the other hand, the services segment is projected to grow at the highest CAGR from 2017 to 2022. Growth can be attributed to the increasing awareness of genomics and reducing DNA sequencing costs, rise in research grants in the field of genomics and repeated usage of the consumables.

Based on technology, the genomics market is segmented into sequencing, microarray, PCR (Polymerase Chain Reaction), nucleic acid extraction and purification and other technologies such as genotyping, and gene editing. In 2017, the PCR technology is expected to account for the largest share of the global market for genomics. On the other hand, owing to the technological advancements in the DNA sequencing, the sequencing technology is expected to grow at the higher CAGR during the forecast period. Based on process, the genomics market is segmented into library preparation, sequencing and data analysis.

The application segment of the market for genomics has been broadly segmented into the genomics market is segmented into diagnostics, drug discovery and development, personalized medicine, agriculture and animal research, and other applications such as biofuels, marine research and coal mines. In 2017, the diagnostics segment is expected to account for the largest share of the global Genomics market. As more genomics applications are added in the future, along with the increasing patient interest in genomic diagnostics are expected to drive the growth of the segment.

End user of the genomics market is segmented into research centers, academic and government institutes, hospital and clinics, pharmaceutical and biotechnology companies, and other end users such as NGO’s and agri-genomics organizations among others. The hospitals and clinics segment is estimated to account for the largest share of the Genomics market in 2017. The large share of this segment is due to increasing demand for pharmacogenomics, growing availability of genetic tests.

Geographically, North America is estimated to account for the largest share of the global Genomics market, followed by Europe. Factors driving this market are research grants and funding by the government institutes in the US, the US Precision Medicine Initiative, and new pan – Canadian program.

However, the high costs of genomic sequencing instruments/systems are expected to restrain the growth of this during the forecast period.

The various players in the Genomics market include Thermo Fisher Scientific (US), Agilent Technologies, (US), Illumina (US), Eurofins Scientific (Germany), QIAGEN (Netherlands), BGI (China), GE Healthcare (UK), Bio-Rad Laboratories (US), F. Hoffmann-La Roche (Switzerland), Oxford Nanopore Technologies (UK), Pacific Biosciences of California (US), and Eppendorf (Germany) among others.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst